Groundbreaking New Treatment Could Reduce The Risk Of Peanut Allergies

KCBS Radio: On-Demand
Monday, November 19th
A new treatment could become the first medication to reduce the severity of peanut allergies. The team of researchers found that by the end of a yearlong trial, two-thirds of children in the study were able to eat two peanuts without an allergic reaction. For people with severe allergies that could be the difference between life and death.

Those results were presented Sunday at the American College ofAllergy, Asthma & Immunology's conference in Seattle.

Dr. Brian Vickery authored the study. He's the director of the Food Allergy Program at Children's Healthcare of Atlanta and an associate professor of pediatrics at the Emory University School of Medicine. He spoke to KCBS Radio anchors Stan Bunger and Susan Leigh Taylor about how the treatment works.